NDA 077337 describes ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE, which is a drug marketed by
Teva and is included in one NDA. Additional details are available on the
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE profile page.
The generic ingredient in ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE is
metformin hydrochloride; rosiglitazone maleate. There are forty-nine
drug master file entries for this compound. Additional details are available on the
metformin hydrochloride; rosiglitazone maleate profile page.